Immune Cell-Based Versus Albumin-Based Ratios As Outcome Predictors in Critically Ill COVID-19 Patients

Overview

Journal J Inflamm Res

Publisher Dove Medical Press

Date 2025 Jan 9

PMID 39780984

Authors

Snjezana Zeba

Maja Surbatovic

Ivo Udovicic

Ivan Stanojevic

Danilo Vojvodic

Goran Rondovic

Katarina Mladenovic

Tanja Abazovic

Almina Hasanovic

Aleksandra N Ilic

Dzihan Abazovic

Wasim Khan

Dragan Djordjevic

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of the retrospective, single-center study was to assess the prognostic value of immune cell-based and albumin-based ratios regarding lethal outcome in critically ill COVID-19 patients.

Patients And Methods: We analyzed 612 adult critically ill COVID-19 patients admitted to the intensive care unit (ICU) between April 2020 and November 2022. Blood measurement on admission to the ICU encompassed complete blood count (CBC), IL-6, C-reactive protein (CRP), albumin, lactate, lactate dehydrogenase (LDH), serum bicarbonate, arterial base deficit/excess (BD/E), and D-dimer. All the measured and calculated parameters were compared between survivors and nonsurvivors, with the outcome measure being hospital mortality.

Results: Immune cell-based ratios [NLR - Neutrophil-to-Lymphocyte Ratio, MLR - Monocyte-to-Lymphocyte Ratio, PLR - Platelet-to-Lymphocyte Ratio, MPV - Mean Platelet Volume, MPV/PC - Mean Platelet Volume-to-Platelet Count Ratio, Derived (d-)NLR ratio - neutrophil count divided by the result of white blood cell (WBC) count - neutrophil count), N/LP - Neutrophil count x 100/Lymphocyte count x Platelet count, CLR - C-reactive protein (CRP)-to-Lymphocyte Ratio, CPR - CRP-to-Platelet Ratio, LLR - Lactate dehydrogenase (LDH)-to-Lymphocyte Ratio, Systemic Immune Inflammation Index (SII) - platelet x neutrophil/lymphocyte count, Systemic Inflammation Response Index (SIRI) - neutrophil x monocyte/lymphocyte count] were investigated. White blood cell and neutrophil counts were significantly higher, while lymphocyte and platelet counts were significantly lower in nonsurvivors. MPV, MPV/PC, NLR, d-NLR, MLR, N/LP, CRP, LDH, CPR, CLR, LLR, SII, and SIRI values were significantly higher in nonsurvivors. Monocyte count and PLR values did not differ significantly between groups. Albumin-based ratios included CRP-to-Albumin Ratio (CAR), Lactate-to-Albumin Ratio (LAR) and LDH-to-Albumin Ratio (LDH/ALB). All values were significantly higher in nonsurvivors.

Conclusion: The only independent predictor of lethal outcomes at ICU admission is the albumin-based LDH/ALB ratio. Most of the other parameters were moderate, although highly significant predictors of mortality in critically ill COVID-19 patients.

References

Djordjevic D, Rondovic G, Surbatovic M, Stanojevic I, Udovicic I, Andjelic T . Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of.... Mediators Inflamm. 2018; 2018:3758068. PMC: 6079471. DOI: 10.1155/2018/3758068. View

Rodrigues H, Silva M, Mantovani M, Silva J, Domingues M, Tanni S . Higher urea-to-albumin ratio is associated with mortality risk in critically ill COVID-19 patients. Clin Nutr ESPEN. 2023; 56:9-12. PMC: 10129333. DOI: 10.1016/j.clnesp.2023.04.017. View

Li X, Wei Y, Xu Z, Li T, Dong G, Liu X . Lymphocyte-to-C-Reactive Protein Ratio as an Early Sepsis Biomarker for Neonates with Suspected Sepsis. Mediators Inflamm. 2023; 2023:9077787. PMC: 10185419. DOI: 10.1155/2023/9077787. View

Samprathi M, Jayashree M . Biomarkers in COVID-19: An Up-To-Date Review. Front Pediatr. 2021; 8:607647. PMC: 8042162. DOI: 10.3389/fped.2020.607647. View

Ullah W, Basyal B, Tariq S, Almas T, Saeed R, Roomi S . Lymphocyte-to-C-Reactive Protein Ratio: A Novel Predictor of Adverse Outcomes in COVID-19. J Clin Med Res. 2020; 12(7):415-422. PMC: 7331862. DOI: 10.14740/jocmr4227. View

Fouladseresht H, Doroudchi M, Rokhtabnak N, Abdolrahimzadehfard H, Roudgari A, Sabetian G . Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19. Cytokine Growth Factor Rev. 2020; 58:32-48. PMC: 7544568. DOI: 10.1016/j.cytogfr.2020.10.002. View

Povoa P, Coelho L, Dal-Pizzol F, Ferrer R, Huttner A, Morris A . How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive Care Med. 2023; 49(2):142-153. PMC: 9807102. DOI: 10.1007/s00134-022-06956-y. View

Li J, Li M, Zheng S, Li M, Zhang M, Sun M . Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19. Biomark Med. 2020; 14(10):827-837. PMC: 7273900. DOI: 10.2217/bmm-2020-0254. View

Liu X, Mu Y . Lymphocyte to C-Reactive Protein Ratio as an Early Biomarker to Distinguish Sepsis from Pneumonia in Neonates. J Inflamm Res. 2023; 16:3509-3517. PMC: 10441656. DOI: 10.2147/JIR.S424897. View

10.

Tjendra Y, Al Mana A, Espejo A, Akgun Y, Millan N, Gomez-Fernandez C . Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers. Arch Pathol Lab Med. 2020; 144(12):1465-1474. DOI: 10.5858/arpa.2020-0471-SA. View

11.

Kang P, Kang W, Li Y, Li T . C-Reactive Protein-to-Albumin Ratio as an Early Biomarker to Identify Sepsis in Neonates with Pneumonia. Mediators Inflamm. 2022; 2022:4711018. PMC: 9303482. DOI: 10.1155/2022/4711018. View

12.

Sang 3rd C, Burkett A, Heindl B, Litovsky S, Prabhu S, Benson P . Cardiac pathology in COVID-19: a single center autopsy experience. Cardiovasc Pathol. 2021; 54:107370. PMC: 8278836. DOI: 10.1016/j.carpath.2021.107370. View

13.

Bajic D, Matijasevic J, Andrijevic L, Zaric B, Lalic-Popovic M, Andrijevic I . Prognostic Role of Monocyte Distribution Width, CRP, Procalcitonin and Lactate as Sepsis Biomarkers in Critically Ill COVID-19 Patients. J Clin Med. 2023; 12(3). PMC: 9917557. DOI: 10.3390/jcm12031197. View

14.

Shokr H, Marwah M, Siddiqi H, Wandroo F, Sanchez-Aranguren L, Ahmad S . Lactate Dehydrogenase/Albumin To-Urea Ratio: A Novel Prognostic Maker for Fatal Clinical Complications in Patients with COVID-19 Infection. J Clin Med. 2023; 12(1). PMC: 9821448. DOI: 10.3390/jcm12010019. View

15.

Selvarajan R, Gopinath S, Mohamad Zin N, Hamzah A . Infection-Mediated Clinical Biomarkers for a COVID-19 Electrical Biosensing Platform. Sensors (Basel). 2021; 21(11). PMC: 8198817. DOI: 10.3390/s21113829. View

16.

Rizzi M, DOnghia D, Tonello S, Minisini R, Colangelo D, Bellan M . COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters. Int J Mol Sci. 2023; 24(8). PMC: 10138390. DOI: 10.3390/ijms24087099. View

17.

Cavusoglu Turker B, Ahbab S, Turker F, Hoca E, Ciftci Ozturk E, Kula A . Systemic Immune-Inflammation and Systemic Inflammation Response Indices are Predictive Markers of Mortality in Inpatients Internal Medicine Services. Int J Gen Med. 2023; 16:3163-3170. PMC: 10387250. DOI: 10.2147/IJGM.S420332. View

18.

Shankar-Hari M, Calandra T, Soares M, Bauer M, Wiersinga W, Prescott H . Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies. Lancet Respir Med. 2024; 12(4):323-336. PMC: 11025021. DOI: 10.1016/S2213-2600(23)00468-X. View

19.

Velez-Paez J, Aguayo-Moscoso S, Castro-Bustamante C, Montalvo-Villagomez M, Jara-Gonzalez F, Baldeon-Rojas L . Biomarkers as predictors of mortality in critically ill obese patients with COVID-19 at high altitude. BMC Pulm Med. 2023; 23(1):112. PMC: 10078096. DOI: 10.1186/s12890-023-02399-3. View

20.

Sirvent J, Baro A, Morales M, Sebastian P, Saiz X . Predictive biomarkers of mortality in critically ill patients with COVID-19. Med Intensiva (Engl Ed). 2021; 46(2):94-96. PMC: 8635425. DOI: 10.1016/j.medine.2021.11.010. View